WO1993020216A1 - Elements cis de proteines des corps oleiferes, servant de signaux de regulation - Google Patents
Elements cis de proteines des corps oleiferes, servant de signaux de regulation Download PDFInfo
- Publication number
- WO1993020216A1 WO1993020216A1 PCT/CA1993/000141 CA9300141W WO9320216A1 WO 1993020216 A1 WO1993020216 A1 WO 1993020216A1 CA 9300141 W CA9300141 W CA 9300141W WO 9320216 A1 WO9320216 A1 WO 9320216A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- seed
- gene
- plant
- regulatory region
- transcriptional
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 120
- 230000001105 regulatory effect Effects 0.000 title claims description 49
- 102000004169 proteins and genes Human genes 0.000 title claims description 47
- 230000014509 gene expression Effects 0.000 claims abstract description 71
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 39
- 108020004414 DNA Proteins 0.000 claims abstract description 34
- 230000031787 nutrient reservoir activity Effects 0.000 claims abstract description 13
- 230000013020 embryo development Effects 0.000 claims abstract description 12
- 238000009825 accumulation Methods 0.000 claims abstract description 9
- 210000001161 mammalian embryo Anatomy 0.000 claims abstract description 5
- 241000196324 Embryophyta Species 0.000 claims description 80
- 230000002103 transcriptional effect Effects 0.000 claims description 53
- 238000000034 method Methods 0.000 claims description 37
- 101710089395 Oleosin Proteins 0.000 claims description 28
- 230000000977 initiatory effect Effects 0.000 claims description 24
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 24
- 240000002791 Brassica napus Species 0.000 claims description 21
- 241000219194 Arabidopsis Species 0.000 claims description 20
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 18
- 229920001184 polypeptide Polymers 0.000 claims description 17
- 238000013518 transcription Methods 0.000 claims description 15
- 230000035897 transcription Effects 0.000 claims description 15
- 235000011293 Brassica napus Nutrition 0.000 claims description 13
- 108020004999 messenger RNA Proteins 0.000 claims description 8
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 240000008042 Zea mays Species 0.000 claims description 7
- 108020001507 fusion proteins Proteins 0.000 claims description 7
- 102000037865 fusion proteins Human genes 0.000 claims description 7
- 230000000295 complement effect Effects 0.000 claims description 5
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 claims description 5
- 108700026220 vif Genes Proteins 0.000 claims description 5
- 244000000626 Daucus carota Species 0.000 claims description 4
- 235000002767 Daucus carota Nutrition 0.000 claims description 4
- 235000007244 Zea mays Nutrition 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 230000010354 integration Effects 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 230000004060 metabolic process Effects 0.000 claims description 3
- 230000001131 transforming effect Effects 0.000 claims description 3
- 230000003584 silencer Effects 0.000 claims description 2
- 101150055581 obp gene Proteins 0.000 claims 2
- 241000219193 Brassicaceae Species 0.000 claims 1
- 235000013399 edible fruits Nutrition 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 description 43
- 239000012634 fragment Substances 0.000 description 29
- 210000004027 cell Anatomy 0.000 description 26
- 239000013612 plasmid Substances 0.000 description 18
- 239000003921 oil Substances 0.000 description 17
- 235000019198 oils Nutrition 0.000 description 17
- 239000000047 product Substances 0.000 description 16
- 108091026890 Coding region Proteins 0.000 description 15
- 241000589158 Agrobacterium Species 0.000 description 14
- 241000894007 species Species 0.000 description 12
- 238000011144 upstream manufacturing Methods 0.000 description 11
- JLIDBLDQVAYHNE-YKALOCIXSA-N Abscisic acid Natural products OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 10
- 239000013598 vector Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 210000002257 embryonic structure Anatomy 0.000 description 8
- 238000003752 polymerase chain reaction Methods 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 244000061176 Nicotiana tabacum Species 0.000 description 7
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 239000013615 primer Substances 0.000 description 7
- 230000009466 transformation Effects 0.000 description 7
- 108020004705 Codon Proteins 0.000 description 6
- 238000010367 cloning Methods 0.000 description 6
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 108700026244 Open Reading Frames Proteins 0.000 description 5
- 230000009261 transgenic effect Effects 0.000 description 5
- 108091035707 Consensus sequence Proteins 0.000 description 4
- 241000209510 Liliopsida Species 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 108010016634 Seed Storage Proteins Proteins 0.000 description 4
- 108091081024 Start codon Proteins 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 241001233957 eudicotyledons Species 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 108700021822 Arabidopsis oleosin Proteins 0.000 description 3
- 235000011331 Brassica Nutrition 0.000 description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 108010058731 nopaline synthase Proteins 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 230000008488 polyadenylation Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 101710168820 2S seed storage albumin protein Proteins 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 241000219198 Brassica Species 0.000 description 2
- 102000053642 Catalytic RNA Human genes 0.000 description 2
- 108090000994 Catalytic RNA Proteins 0.000 description 2
- 102000007999 Nuclear Proteins Human genes 0.000 description 2
- 108010089610 Nuclear Proteins Proteins 0.000 description 2
- 101710152905 Oleosin 5 Proteins 0.000 description 2
- 108700001094 Plant Genes Proteins 0.000 description 2
- 108700026226 TATA Box Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 2
- 239000005516 coenzyme A Substances 0.000 description 2
- 229940093530 coenzyme a Drugs 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 2
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- -1 fatty acyl coenzyme A Chemical compound 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000010152 pollination Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 108091092562 ribozyme Proteins 0.000 description 2
- 230000008117 seed development Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 238000002741 site-directed mutagenesis Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 108010052418 (N-(2-((4-((2-((4-(9-acridinylamino)phenyl)amino)-2-oxoethyl)amino)-4-oxobutyl)amino)-1-(1H-imidazol-4-ylmethyl)-1-oxoethyl)-6-(((-2-aminoethyl)amino)methyl)-2-pyridinecarboxamidato) iron(1+) Proteins 0.000 description 1
- 108020005029 5' Flanking Region Proteins 0.000 description 1
- FVFVNNKYKYZTJU-UHFFFAOYSA-N 6-chloro-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(Cl)=N1 FVFVNNKYKYZTJU-UHFFFAOYSA-N 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 235000012284 Bertholletia excelsa Nutrition 0.000 description 1
- 244000205479 Bertholletia excelsa Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 241000220243 Brassica sp. Species 0.000 description 1
- 101100148606 Caenorhabditis elegans pst-1 gene Proteins 0.000 description 1
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 108700012941 GNRH1 Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 102000007625 Hirudins Human genes 0.000 description 1
- 108010007267 Hirudins Proteins 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- 102400000243 Leu-enkephalin Human genes 0.000 description 1
- 108010022337 Leucine Enkephalin Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 102000008072 Lymphokines Human genes 0.000 description 1
- 108010074338 Lymphokines Proteins 0.000 description 1
- 101710202365 Napin Proteins 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 241000201976 Polycarpon Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 101710101744 Sulfur-rich protein Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000433 anti-nutritional effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 235000020113 brazil nut Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 150000001945 cysteines Chemical class 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005489 dwarf bean Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
- 229940006607 hirudin Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- URLZCHNOLZSCCA-UHFFFAOYSA-N leu-enkephalin Chemical compound C=1C=C(O)C=CC=1CC(N)C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=CC=C1 URLZCHNOLZSCCA-UHFFFAOYSA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- SBWGZAXBCCNRTM-CTHBEMJXSA-N n-methyl-n-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]octanamide Chemical compound CCCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SBWGZAXBCCNRTM-CTHBEMJXSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 101150072645 pea gene Proteins 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000023276 regulation of development, heterochronic Effects 0.000 description 1
- 230000037425 regulation of transcription Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6478—Aspartic endopeptidases (3.4.23)
- C12N9/6483—Chymosin (3.4.23.4), i.e. rennin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
- C12N15/823—Reproductive tissue-specific promoters
- C12N15/8234—Seed-specific, e.g. embryo, endosperm
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/23—Aspartic endopeptidases (3.4.23)
- C12Y304/23004—Chymosin (3.4.23.4), i.e. rennin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Definitions
- This invention relates to upstream DNA sequences and their use to control expression of genes in developing plant seeds and their use.
- Plants like other organisms both prokaryotic and eukaryotic, contain conserved or consensus sequences upstream (5') of the transcriptional start site of genes which appear capable of regulating transcriptional rates. In eukaryotes, these sequences include a motif found typically about 25 bp 5' to the transcriptional initiation site which has the sequence TATAA/TAA/T and is referred to as a TATA box. The role of this TATA box appears to be to define the transcriptional start for RNA polymerase II. A second upstream sequence is referred to as a CAAT box.
- promoters In general, 5' of the promoter region and most frequently within 2000 bases of if are cis-acting elements which confer a variety of properties on the promoter and which can modulate transcriptional activity in either a constitutive or a non-constitutive manner. These cis-acting sequences may be referred to as enhancers (if they are responsible for increases in transcription) or silencers (if they are responsible for
- SUBSTITUTE SHEET decreases or suppression of transcription.
- Enhancers and silencers are frequently the sites at which nuclear proteins bind or interact.
- the modulating nuclear proteins are called trans-acting factors. They are considered to be very important for non-constitutive or regulated expression as they may be the major determinant of the activity of a gene in a particular tissue or organ or in response to an external stimulus. The relationship between this protein binding and the enhancer/silencer element may determine the transcriptional activity.
- the isolation of genes which are activated by heat, light or chemicals such as endogenous hormones or are activated in specific organs such as seeds, leaves or flowers has permitted analysis of factors which may determine how expression is regulated.
- chimeric genes which contain the promoter and optionally cis-elements from a given regulated gene and a coding sequence of a reporter protein not normally associated with that promoter gives rise to regulated expression of the reporter.
- the use of promoters from seed-specific genes for the expression of sequences in seed of genes that are either not normally expressed in a seed-specific manner or those that require an altered pattern of expression has been attempted on only a few occasions.
- chimeric genes designed for seed-specific expression have used seed-storage protein regulatory signals and promoters.
- organ or tissue-specific regulatory sequences used to produce tissue- or organ-specific expression in transformed plants.
- organ-specific regulatory sequences used to produce tissue- or organ-specific expression in transformed plants.
- regulated gene expression in non-seed protein chloramphenicol acetyl transferase could be expressed in a light-regulated and organ-specific manner in transgenic plants if the coding sequence for the reporter protein was fused with the promoter and upstream sequences from a pea gene encoding ribulose bisphosphate carboxylase (Fluhr, Science (1986), 232:1106-1112).
- Sengupta-Gopalan et al. Proc. Natl. Acad. Sci. USA, (1985)£:3320-3324 reported expression of a major storage protein of french beans, called ⁇ -phaseolin, in tobacco plants. The gene expressed correctly in the seeds and only at very low levels elsewhere in the plant. However, the constructs used by Sengupta-Gopalan were not chimeric. The entire ⁇ -phaseolin gene including the native 5'-flanking sequences were used. Subsequent experiments with other species (Radke et al. (1988) Theor. App. Genet.
- sequences upstream of the transcriptional start may be used to confer tissue/organ specificity to a gene introduced into plants by genetic engineering.
- Examples include engineering seed-specific gene regulation (Radke et al. (1988) vide supra; Bustos et al. (1989), Plant Cell, 1:839-853).
- sequences upstream of the coding sequences of seed proteins were linked to a reporter tag (either as RNA or protein) and seed specificity was conferred on expression of the reporter. These were all storage protein genes rather than oleosins. Seed storage proteins have different temporal expression patterns from oleosins.
- DeClercq et al. Plant Physiol., (1990), 24:970-979 used the promoter of the Arabidopsis 2S albumin and combined coding sequences from both the Arabidopsis and Brazil nut 2S albumins. Fusions were made in regions showing low conservation. Transformation of both tobacco and Brassica napus yielded seed-specific expression and correct accumulation of the modified storage proteins. Levels of expression were between 0.05% and 0.3% of total cellular protein.
- Another example of this form of seed-specific expression of foreign sequences was the expression of leu-enkephalins in seeds.
- a chimeric DNA sequence encoding a 2S albumin and a short oligonucleotide encoding leu-enkephalin (a pentapeptide) was included in the albumin coding sequences between the 6th and 7th cysteines of the native protein (Vanderkerhove et al. Bio/Technology, (1989) 7:929-932). Again this gene expressed in a seed-specific manner allowing the accumulation of up to 50 nmol leu-enkaphalin per g of seed.
- the method includes the steps of transforming a plant cell with a DNA construct comprising the regulatory sequence and a DNA sequence other than the open reading frame native to the regulatory sequence, generating a plant from the transformed cell and growing it under conditions whereby seed is produced and the DNA sequence is expressed under the transcriptional control of the regulatory region.
- Fig. 1 shows a schematic diagram of vector pPAW4 enclosing an oleosin regulatory sequence, an initiation codon, foreign DNA to be expressed, an oleosin terminator sequence and an ampicillin resistance gene.
- Fig. 2A shows the DNA sequence of an Arabidopsis genomic clone encoding a 18KDa oil-body protein.
- the open reading frame is interrupted by a short intron (which is marked) and the two exons are translated and indicated in IUPAC single letter amino-acid codes.
- Fig. 2B shows the restriction fragment from an Agrobacterium EMBL3 genomic library which encloses Hie Arabidopsis 18KDa oil-body protein coding sequence. The approximate position of the coding region is highlighted.
- Fig. 3 shows the effects of 10 M ABA on the developmental expression of oleosin mRNA using a Northern blot analysis of total RNA.
- A) (70 / ⁇ g per lane) using 50 ng 32 ? dCTP labelled OB990 as a probe (spec. act. 10 9 dpm/ ⁇ g DNA).
- RNA of roots (R), callus (Ca), Cotyledons (Co), leaves (L), and 24-day post- anthesis zygotic embryos (E) was probed with 50 ng of 32 P dCTP labelled OB990 (spec. act. 10 dpm/ ⁇ g DNA).
- Fig. 5 shows the developmental sensitivity of oil body protein synthesis to applied ABA.
- An estimated 10,000 dpm were loaded per well for paired samples of controls (lanes A,C,E,G) and ABA-treated (lanes B,D,F,H). All samples were treated for 2d with ABA, then labeled for 4 h with 1.85 MBq/mL ⁇ SJmethionine.
- Lanes A and B 10-d-old cultures, sieved on 62 m screens to obtain globular embryos.
- Lanes C and D 13-d-old cultures sieved on 125 ⁇ m screens to obtain heart stage embryos.
- Lanes E and F 17-d-old cultures, sieved on 250 m screens to obtain torpedo to early cotyledonary embryos.
- Lanes G and H 25-d-old cultures, sieved on 500 m screens to obtain cotyledonary stage embryos.
- DNA constructs which allow for modulation of plant phenotype in seed, particularly during early phases of embryogenesis.
- the DNA constructs provide for regulation of transcription in seed, using 5' untranslated sequences from genes active from the late globular stage through to embryo maturity (cotyledonary stage).
- Downstream from and under transcriptional initiation regulation of an oil body protein gene initiation region will be a DNA sequence of interest which will be prepared which allow for integration of the transcription cassette into the genome of a plant cell.
- a multiple cloning site downstream from the seed specific transcriptional initiation region may be included so that the integration construct may be employed for a variety of DNA sequences in an efficient manner.
- oil body protein gene preferably an oil body protein gene expressed in dicotyledonous oil seeds. It has been reported that oil-body proteins accumulate considerably later than either oils (triacylglycerides) or storage proteins. This later expression would limit the value of any promoters associated with these genes for seed-specific expression as they could not be used for modification of expression of genes during early phases of embryogenesis. Surprisingly, however, expression of these genes in dicotyledonous oilseeds was found to occur much earlier than had hitherto been believed. Thus, the promoters and upstream elements of these genes are valuable for a variety of uses involving the modification of metabolism during phases of embryogenesis which precede the accumulation of storage proteins.
- Oil-body proteins have been identified in a wide range of taxonomically diverse species (see, for example, Moreau et al. Plant Physiol. (1980), 65:1176-1180; Qu et al. Biochem. J., (1986) 225:57-65). These proteins are uniquely localized in oil-bodies and are not found in organelles of vegetative tissues. In Brassica napus (rapeseed) there are at least three polypeptides associated with the oil-bodies of developing seeds (Taylor et al. (1990), Planta, l£i: 18-26). The numbers and sizes of oil-body associated proteins may vary from species to species. In corn, for example, there are four immunologically distinct polypeptides found in oil-bodies (Bowman- Vance and Huang, 1988, J. Biol.
- Oleosins have been shown to comprise regions of alternate hydrophilicity, hydrophobicity and hydrophilicity (Bowman-Vance and Huang, 1987, J. Biol. Chem., 262:11275-11279).
- the amino acid sequences of oleosins from corn, rapeseed and carrot have been obtained. See Qu and Huang, 1990, J. Biol. Chem., 265:2238-2243, Hatzopoulos et al. 1990, Plant Cell, 2:457-
- oleosin may comprise between 8% (Taylor et al. 1990, Planta, 181:18-26) and 20% (Murphy et al. 1989, Biochem. L, 258:285-2931 of total seed protein. Such a level is comparable to that found for many seed storage proteins.
- embryogenesis typically goes through a series of defined phases.
- embryogenesis includes the following phases: globular stage, heart stage, torpedo stage, and cotyledonary stage.
- the definition of these terms is provided by Ray, Steves, and Fultz in Botany, (Saunders College).
- the transcriptional initiation region will be obtainable from a gene which is expressed in the early formation of seed. Desirably the transcriptional initiation region maintains its activity from the late globular through cotyledonary stage, more desirably continues active from the globular stage through the heart, torpedo and cotyledonary stages of embryogenesis.
- a transcriptional initiation region having a nucleotide sequence sufficiently similar to that of a natural oil body protein gene transcriptional initiation region sequence to provide for transcription in the early formation of seed. The sequence may be naturally occurring, synthetic or partially synthetic.
- the transcriptional initiation region from the oil body protein generally will be provided in a cassette which will include in the 5'-3' direction of transcription, a transcriptional initiation region, a DNA sequence of interest and a transcriptional termination region, wherein the transcriptional regulatory regions are operably joined and functional in plant cells.
- One or more introns may also be present.
- a DNA to be used in the final construct may be restricted and operably joined to other DNA to be used in the final construct, where each of the partial constructs may be cloned in the same or different plasmids.
- a coding sequence with a compatible restriction site may be ligated at the position corresponding to codon #1 of the oil- body protein gene. A schematic diagram of this substitution is shown in figure 1.
- the recombinant coding sequence may be inserted in such a way that it completely replaces the coding sequence of the oil-body protein gene and is thus flanked at its 3' end by the oil-body protein gene terminator and polyadenylation signal.
- polymerase chain reaction amplification may be carried out to produce DNA fragments containing the transcriptional initiation region conveniently flanked by restriction sites.
- the amplified fragments can be joined to the coding sequence for a polypeptide of interest, in a transcriptional or translational fusion, for example, to produce a chimeric gene in which the coding sequence of the polypeptide of interest is transcribed under the control of the transcription initiation region on the PCR amplified fragment.
- the transcriptional initiation region may be native to or homologous to the host cell, or foreign or heterologous to the host cell. By foreign is intended that the transcriptional initiation region is not found in the wild-type host into which the construct comprising the transcriptional initiation region is inserted.
- the regulatory sequence comprises DNA of up to 1.5 Kb 5' of the translational start of an oil-body protein gene. This sequence may be modified at the position corresponding to the first codon of the desired protein by site-directed mutagenesis (Kunkel TA, 1985, Proc. Natl. Acad. Sci. USA, £2:488-492) or by introduction of a convenient linker oligonucleotide by ligation if a suitable restriction site is found near the N-terminal codon.
- the DNA sequence of interest in some cases it will be desirable to express the DNA sequence of interest as a fusion protein, particularly as a fusion protein with the oil body protein.
- the DNA sequence of interest can be inserted by routine techniques into the oil body protein coding sequence, in frame with the oil body protein coding sequence, such that transcription of the chimeric gene will produce a fusion protein.
- the fusion protein will preferably contain the coding region for amino acids number 44 through 122 in the Arabidopsis oil body protein as shown in Figure 2A, or the equivalent region from an oil body protein of a species other than Arabidopsis, to provide for transport to the oil body in cases where this is desirable.
- at least two approaches may be used.
- the first is to use the Arabidopsis clone described in the Examples as a probe in genomic libraries of other plant species.
- This clone will hybridize well with oleosin clones from closely related species, in particular, essentially all cruciferous plants.
- species which are evolutionarily divergent from Arabidopsis for example, solanaceae, leguminaceae and all monocotyledons
- an alternative method involves the use of an antibody raised against the gene product of an oleosin clone such as the Arabidopsis clone.
- This antibody may be used to screen a seed-derived cDNA expression library, for example using lambda gtll; Huynh et al. (1985) in cDNA Cloning, Vol. 1, A Practical Approach, Ed. Grover IRL Press, pp. 49-78.
- This approach yields a cDNA clone of the oleosin for the new species which may then be used to isolate the genomic clone from a genomic library of that species by standard DNA hybridization techniques.
- the DNA sequence of interest may be any open reading frame encoding a peptide of interest, for example, an enzyme, or a sequence complementary to a genomic sequence, where the genomic sequence may be at least one of an open reading frame, an intron, a non-coding leader sequence, or any other sequence where the complementary sequence will inhibit transcription, messenger RNA processing, for example splicing or translation.
- the DNA sequence of interest may be synthetic, naturally derived or a combination thereof. Depending upon the nature of the DNA sequence of interest, it may be desirable to synthesize the sequence with plant preferred codons.
- the plant preferred codons may be determined from the codons of highest frequency in the proteins expressed in the largest amount in the particular plant species of interest.
- the DNA sequence of interest may encode any of a variety of recombinant proteins.
- recombinant proteins which might be expressed by this procedure include anticoagulants, such as Hirudin, lymphokines such as those of the interleukin family, peptide hormones such as gonadotrophin releasing hormone, immunological reagents such as multi or single-chain antibodies and a variety of industrial valuable enzymes such as proteases, lipases and polyglucan hydrolases.
- the termination region which is employed will be primarily one of convenience, since the termination regions appear to be relatively interchangeable.
- the termination region may be native with the DNA sequence of interest, or may be derived from another source.
- Convenient termination regions are available and include the 3' end of the oil body protein gene terminator and polyadenylation signal from the same gene from which the 5' regulatory region is obtained.
- a different terminator and polyadenylation signal may be employed with similar results, for example, the terminator of the nopaline synthase gene of
- the expression cassette may additionally contain a means for identifying transformed cells and/or selecting for transformed cells.
- the recombinant gene may be linked with a constitutively expressed selectable marker such as a gene for antibiotic resistance or herbicide resistance or a screenable marker, such as a gene conferring bioluminescence or colored properties to transformed cells.
- the DNA sequence of interest flanked at its 5' end by the oil-body protein promoter and regulatory sequences and at its 3' end by a terminator may be introduced into a suitable transformation vector including Agrobacterium Ti or binary plasmids, or a simple cloning plasmid (e.g., pUC19, pBR322) for use in direct DNA uptake to plant cells via microinjection, electroporation, PEG- mediated uptake or a biolistic method.
- Agrobacterium Ti or binary plasmids or a simple cloning plasmid (e.g., pUC19, pBR322) for use in direct DNA uptake to plant cells via microinjection, electroporation, PEG- mediated uptake or a biolistic method.
- Transformed plants may be obtained from the transformed cells using standard regeneration protocols (see for example: Moloney et al. (1989), Plant Cell Rep., £:238-242) compatible with the transformation method.
- the expression cassette, constructed as described above, expresses essentially preferentially in developing seeds.
- the plant cells which have been transformed with an appropriate fusion peptide therefore are grown into plants in accordance with conventional ways and allowed to set seed. See, for example, McCormick et al., Plant Cell Rep. (1986) 5:81-84.
- Two or more generations may be grown and either pollinated with the same transformed strain or different strains, identifying the resulting hybrid having the desired phenotypic characteristic, to ensure that the subject phenotypic characteristic is stably maintained and inherited and then seeds harvested for isolation of the peptide of interest or for use to provide seeds with the new phenotypic property.
- the regenerated plants are then cultivated identically to non-recombinant plants in growth chambers, greenhouses or in the field and will show seed-specific expression of the recombinant gene at the mRNA level and often at the level of polypeptide or protein.
- polypeptide/protein will itself be valuable and could be extracted and, if desired, further purified.
- polypeptide/protein or even the mRNA itself may be used to confer a new biochemical phenotype upon the developing seed.
- New phenotypes could include such modifications as altered seed-protein or seed oil composition, enhanced production of pre-existing desirable products or properties and the reduction or even suppression of an undesirable gene product using antisense, ribozyme or co-suppression technologies (Izant and Weintraub (1984), Cell 36: 1007-1015, antisense; Hazelhoff and Gerlach (1988), Nature 334:585-591, ribozyme; Napoli, et al. (1990), Plant Cell, 2:279-289, co-suppression).
- the transformation has been performed to produce a new seed protein or peptide which requires extraction, this can be done using aqueous extraction with or without low concentrations of detergents, such as non- denaturing amounts of sodium dodecyl sulphate (SDS), Triton-X-100, Tween 20, MEGA-8 or any other detergent known not to irreversibly inactivate the desired protein.
- detergents such as non- denaturing amounts of sodium dodecyl sulphate (SDS), Triton-X-100, Tween 20, MEGA-8 or any other detergent known not to irreversibly inactivate the desired protein.
- SDS sodium dodecyl sulphate
- Triton-X-100 Triton-X-100
- Tween 20 MEGA-8
- any other detergent known not to irreversibly inactivate the desired protein dry seeds are ground by hand or in a mechanical grinder to produce an aqueous slurry or suspension. This can be resolved into three phases (particulate, aqueous soluble,
- the product may be further purified in each of these phases and after solublization, may be selectively precipitated by the use of ammonium sulfate or purified using column chromatography, for example, using ion exchange, gel filtrates or affinity matrices.
- ammonium sulfate or purified using column chromatography, for example, using ion exchange, gel filtrates or affinity matrices.
- column chromatography for example, using ion exchange, gel filtrates or affinity matrices.
- a dicot oleosin regulatory sequence For dicot seed-specific expression, a dicot oleosin regulatory sequence should be employed.
- the reported sequence can be used in a wide variety of dicotyledonous plants, including all members of the Brassica genus and crucifers in general. Solanaceous plants, such as tobacco and tomato, also recognize the sequences and show correct regulation of expression in developing seeds.
- This invention has a variety of uses which include improving the intrinsic value of plant seeds by their accumulation of altered polypeptides or novel recombinant peptides or by the incorporation or elimination of a metabolic step. In its simplest embodiment, use of this invention may result in improved protein quality (for example, increased concentrations of essential or rare amino acids), improved liquid quality by a modification of fatty acid composition, or improved or elevated carbohydrate composition. Examples include the expression of sulfur-rich proteins, such as those found in lupins or brazil nuts in a seed deficient in sulphurous amino acid residues.
- a fatty acyl coenzyme A (COA) a transferase enzyme capable of modifying fatty acid ratios in triglycerides (storage lipid) could be expressed.
- COA fatty acyl coenzyme A
- the protein could also be a peptide which has pharmaceutical, industrial or nutritional value.
- the peptide could be extracted from the seed and used in crude or purified form, as appropriate for the intended use.
- the protein could be one truly foreign to the plant kingdom, such as an animal hormone, enzyme, lymphokine, anticoagulant, or the like could be expressed in seed.
- the heterologous protein could then be extracted from the seeds and used for experimental, nutritional or pharmaceutical purposes after partial or complete purification.
- the following examples are offered by way of illustration and not by limitation. EXAMPLES Example 1
- the oil body protein gene from Arabidopsis was isolated on a 15kb insert present in a clone from an Arabidopsis thaliana v. Columbia genomic library in phage ⁇ EMBL3A by hybridization to a B. napus oleosin clone.
- 1.8kb fragment containing approximately 868 base pairs 5' of the oleosin protein translational start was subcloned into a plasmid vector.
- the Arabidopsis 18 KDa oleosin gene is conveniently cloned as a 1803 bp fragment flan-ted by Ncol and Kpnl sites in a vector called pPAW4 (see Figure 1).
- pPAW4 a vector
- two modifications must be made. Firstly, using the technique of site-directed mutagenesis (Kunkel, supra) mutations at positions -2, -1 and +4 are introduced using a mis-matched oligonucleotide.
- the mutations required are A to T (-2), A to C (-1) and G to A (+4). These mutations have the effect of creating a BspHl site at positions -2 to +4.
- the BspHl site (T/CATGA) encloses the ATG initiation codon and gives a recessed end compatible with an Ncol cut.
- a second modification involves digestion with EcoRV and Mscl which releases a 658 bp fragment containing most of the coding sequence of the native oleosin. This leaves blunt ends at the cut sites which on separation of the vector and an ancillary sequence from the EcoRV-Mscl fragment, permits rec cularization of the vector-promoter-terminator combination.
- This recircularization is performed in the presence of an oligonucleotide linker containing restriction sites not found in the original 1803 Kb fragment.
- a plasmid containing all the upstream sequences of the oleosin gene, a transcriptional start site and an initiation codon embedded in a BspHl site is obtained. Thirty-one bases downstream of this is a short polylinker containing one or more unique restriction sites.
- the foreign sequence should have, or should be modified to contain, a BspHl or Ncol site at the initial ATG position. For sequences to be expressed as proteins this will assure conservation of the distance between the "cap" site and the initiator codon.
- the DNA sequence to be inserted should terminate with a cohesive end of a restriction site not found on the plasmid.
- the polylinker interposed into the expression cassette may be chosen with this site in mind. Digesting the plasmid with BspHl and the appropriate restriction enzyme for the 3' end of the foreign sequence will ensure that a directional cloning of the desired DNA fragment may be effected. Using appropriate ligation conditions, the plasmid expression cassette with BspHl and a site compatible with the desired DNA fragment are incubated together to produce a ligated product as shown in Figure 1. The complete construct from Ncol-Kpnl is now excised and introduced into an appropriate plant transformation vector such as an
- Agrobacterium plasmid i order to introduce the construct into common Agrobacterium plasmids such as Bin 19 (Bevan, Nucl. Acid Research (1984) 12:8711-8721) it may be necessary to use one of the additional restriction sites in plasmid pPAW4.
- the plasmid could be cut with Smal and Kpnl.
- the resulting purified fragment then is ligated to a Kpnl oligonucleotide linker and digested withy Kpnl. This provides a non-directional Kpnl fragment for introduction into Bin 19.
- the construct may be excised with Kpnl and BamHl and ligated directionally into pBIN 19 previously cut with the same restriction enzymes.
- the resulting Agrobacterium binary plasmid is mobilized into a disarmed Agrobacterium strain by tripartite mating (Ditta, et al. (1980), PNAS
- the Agrobacterium harboring the recombinant Bin 19 is used to transform any susceptible plant, e.g., Brassica sp. by standard explant co- cultivation (Horsch et al. (1985), supra).
- the transformed cells are selected in culture with kanamycin using the co-transferred antibiotic resistance genes (neomycin phosphotransferase) also contained between the T-DNA borders of pBin 19.
- These transformed cells are induced to regenerate whole plants by standard procedures (e.g. for an oilseed such as rapeseed. £ ⁇ £, Moloney et al. Plant Cell Rep., (1989), 8: 238-242).
- the regenerated plants are permitted to flower and are self-fertilized (or may be cross-fertilized).
- this product may be isolated from aqueous extractions of the mature seed and subsequent fractionation of the slurry by centrifiigation (30 min at 100,000 xg). Depending on the desired product it may partition with any one of the three phases obtained. It may be localized in the pellet, aqueous soluble phase or in the lipid film on the surface of the centrifiiged sample.
- the purpose of the expression may be to divert metabolism in the seed thus changing the phenotype of the seed (e.g. by altering size or colour of the seed, changing the ratio of fatty acid residues in the seed or interdicting a particular metabolic step considered to render the seed less useful or valuable.
- Such metabolic steps might include the production of antinutritional secondary products which reduce the value or desirability of the seed when present. i such cases, the seed, per se, is simply harvested and used in accordance with usual procedures.
- a number of constructs containing varying amounts of the DNA sequence from the 5' transcriptional initiation region of the Arabidopsis oleosin gene joined operably to the coding region for ?-glucuronidase (GUS) were prepared using PCR.
- the constructs are designated according to the amount of the oleosin 5' region contained, for example, the 2500 construct has approximately
- a PCR based approach was used. This involves the use of the polymerase chain reaction to amplify the precise sequence desired for the expression analysis.
- two oligonucleotide primers were synthesized (Milligen-Biosearch, Cyclone DNA synthesizer) having the following sequences:
- Pst 1 oleosin seq 5' primer 5-CA_ ⁇ Q£AQ ⁇ AACTCTCrGGTAA 3' (GVR10)
- the italicized bases correspond to nucleotide positions -833 to -817 in the sequence reported in Fig. 2A.
- the additional nucleotides 5' of this sequence in the primer are not identical to the oleosin gene, but were included in order to place a Pstl site at the 5' end of the amplification product. The Pstl site is underlined.
- a second (3') primer was synthesized which had the following sequence:
- This primer contains the precise complement (shown in italics) to the sequence reported in Fig. 2A from base -13 to -30. In addition, it contains a further 13 bases at the 5' end. This sequence is not complementary to the oleosin gene, but was added to provide two (overlapping) restriction sites, Smal and
- PCR amplification was performed using the enzyme Taq polymerase (Peririn-Elmer-Cetus) using the conditions recommended by the enzyme manufacturer and a temperature program of 92°C (denaturation) 1 min, 55°C (annealing) 1 min and 72°C (elongation) 1 min.
- the template was the oleosin genomic clone shown in Figure 2B, top panel, which in the original ⁇ library isolate contained approximately 15 kilobases of Arabidopsis DNA.
- the amplification product (OLEO p800) was gel purified on 0.7% agarose, recovered using the glass bead method of Vogelstein and Gillespie (Preparative and analytical purification of DNA from agarose. Proc. Natl. Acad. Sci. USA 1979 76:615-619) and digested with Pstl. The digestion product was gel purified and end filled using DNA polymerase Klenow fragment then cut with Smal to produce a blunt ended fragment.
- the resulting plasmid was then cut with BamHl to yield the fragment OLEOp800 flanked by BamHl sites.
- This fragment, BamHl-OLEO800 was cloned into the BamHl sites of a BamHl digested plasmid designated HspGUS1559.
- HspGUS1559 is a plasmid used as a binary vector in Agrobacterium, derived from the vector pCGN 1559 (MacBride and Summerfeldt, 1990, Plant Molecular Biology, 14, 269-276) with an insert containing heat shock promoter (flanked by BamHl sites), the jS-glucuronidase open reading frame and a nopaline synthase terminator (derived from pB1221, Jefferson RA in Cloning Vectors 1988, Eds. Pouwels P., Enger-Valk BE, Brammer WJ., Elsevier Science Pub BV, Amsterdam section VH, Aill).
- Agrobacterium (strain EHA101) by electroporation as described above (Rogers et al., 1988, Plant Molecular Biology Manual, A2: 1-12, Eds. Gelvin S. and Schilperoort, R. Kluwer Academic, Dordrecht, Netherlands).
- the resultant Agrobacterium strain (EHA 101 x pOLEOp800GUS1559) was used to transform Brassica napus plants by the method of Moloney et al. (Moloney, M.M., Walker, J.M., Sharma, K.K. (1989) Plant Cell Reports 8:238-242) or tobacco plants by the method of Horsch et al.(Horsch et al. Science (1985) 227:1299-1302).
- the resultant transgenic plants were allowed to set seed, and GUS expression assays (Jefferson R.A. (1987), Plant Mol. Biol. Rep. 5 387-405) were performed on the developing seeds and also on non-reproductive plant parts as controls. GUS expression reported is an average obtained from approximately five seeds from each of approximately five different transgenic plants.
- the other constructs were prepared by the same PCR method described above using the appropriate primers for amplifying the -2500 fragment, the -1200 fragment, the -600 fragment or the -200 fragment.
- the results in Brassica napus expressed as specific activity of GUS enzyme are shown in Table I.
- the results in tobacco are shown in Table ⁇ .
- the 3' oleosin terminator was replaced by a terminator derived from the nopaline synthase gene of Agrobacterium.
- the sequence in the 800 construct is sufficient to drive the desired expression profile independent of ancillary sequences.
- Promoter/GUS Seed Root Leaf Stem Seed (Late- Construct (Torpedo Stage) Cotyledonary ' )
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Toxicology (AREA)
- Developmental Biology & Embryology (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/313,098 US5792922A (en) | 1992-04-02 | 1993-04-02 | Oil-body protein cis-elements as regulatory signals |
KR1019940703487A KR100278456B1 (ko) | 1992-04-02 | 1993-04-02 | 조절 신호인 지방체 단백질 시스-요소 |
DE69332538T DE69332538T2 (de) | 1992-04-02 | 1993-04-02 | Cis elemente des ölkörperproteins als regulationische signale |
JP51693593A JP3660354B2 (ja) | 1992-04-02 | 1993-04-02 | 調節シグナルとしてのオイルボディタンパク質シスエレメント |
EP93907716A EP0633940B1 (fr) | 1992-04-02 | 1993-04-02 | Elements cis de proteines des corps oleiferes, servant de signaux de regulation |
CA002133417A CA2133417C (fr) | 1992-04-02 | 1993-04-02 | Elements cis de proteine de substance huileuse, utilises comme signaux regulateurs |
UA94105980A UA41319C2 (uk) | 1992-04-02 | 1993-04-02 | Спосіб експресії послідовності днк,що представляє інтерес,у клітині насіння,химерний ген,експресуюча касета,ізольована регуляторна ділянка транскрипції,спосіб зміни специфічного для насіння метаболізму, спосіб одержання нових поліпептидів у насінні,ізольована днк, спосіб експресії послідовності днк,що представляє інтерес,у рослині-хазяїні,спосіб одержання очищеного поліпептиду,що представляє інтерес,спосіб одержання поліпептиду, що представляє інтерес, в олійному тілі |
AU38844/93A AU678154B2 (en) | 1992-04-02 | 1993-04-02 | Oil-body protein cis-elements as regulatory signals |
RU94046161A RU2148647C1 (ru) | 1992-04-02 | 1993-04-02 | Способ экспрессии представляющей интерес последовательности днк в клетке семени, днк-конструкция, кассета экспрессии, изолированный регуляторный участок транскрипции и способ изменения специфичного для семян метаболизма |
AT93907716T ATE229076T1 (de) | 1992-04-02 | 1993-04-02 | Cis elemente des ölkörperproteins als regulationische signale |
FI944550A FI120314B (fi) | 1992-04-02 | 1994-09-30 | Öljyonteloproteiini-cis-elementit säätelysignaaleina |
NO19943664A NO321501B1 (no) | 1992-04-02 | 1994-09-30 | Fremgangsmate for a uttrykke en DNA-sekvens i en frocelle og for a endre frospesifikk metabolisme, samt DNA-konstruksjon, ekspresjonskassett, isolert transkripsjonsregulerende omrade, plante, fro og isolert DNA. |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65983591A | 1991-02-22 | 1991-02-22 | |
US86235592A | 1992-04-02 | 1992-04-02 | |
US07/862,355 | 1992-04-02 | ||
CAPCT/CA92/00161 | 1992-04-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993020216A1 true WO1993020216A1 (fr) | 1993-10-14 |
Family
ID=27097908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA1993/000141 WO1993020216A1 (fr) | 1991-02-22 | 1993-04-02 | Elements cis de proteines des corps oleiferes, servant de signaux de regulation |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1993020216A1 (fr) |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996021029A1 (fr) * | 1994-12-30 | 1996-07-11 | University Technologies International, Inc. | Proteines de corps huileux utilisees comme supports de proteines de valeur elevee |
WO1998045461A1 (fr) * | 1997-04-09 | 1998-10-15 | Rhone-Poulenc Agro | Region regulatrice 5' d'oleosine servant a la modification de la composition lipidique de graines vegetales |
US5850026A (en) * | 1996-07-03 | 1998-12-15 | Cargill, Incorporated | Canola oil having increased oleic acid and decreased linolenic acid content |
US5981841A (en) * | 1996-08-30 | 1999-11-09 | Monsanto Company | Early seed 5' regulatory sequence |
EP1002067A1 (fr) * | 1997-07-18 | 2000-05-24 | Carnegie Institution Of Washington | Region de regulation precoce puissante de gene specifique aux semences |
WO2000031283A2 (fr) * | 1998-11-20 | 2000-06-02 | Dow Agrosciences Llc | Sequences regulatrices utiles pour l'expression genetique dans des tissus embryonnaires vegetaux |
WO2001090386A2 (fr) * | 2000-05-24 | 2001-11-29 | The University Of British Columbia | Region regulatrice de genes promouvant une transcription precoce specifique de graines |
US6586658B1 (en) | 1998-03-06 | 2003-07-01 | Metabolix, Inc. | Modification of fatty acid metabolism in plants |
WO2004076617A2 (fr) | 2003-02-27 | 2004-09-10 | Basf Plant Science Gmbh | Procede de production d'acides gras polyinsatures |
WO2005083053A2 (fr) | 2004-02-27 | 2005-09-09 | Basf Plant Science Gmbh | Procede pour produire des acides gras $g(v)-3 insatures dans des organismes transgeniques |
US7026526B2 (en) | 2000-02-11 | 2006-04-11 | Metabolix, Inc. | Multi-gene expression constructs containing modified inteins |
US7091401B2 (en) | 1991-02-22 | 2006-08-15 | Sembiosys Genetics Inc. | Expression of epidermal growth factor in plant seeds |
WO2006100241A2 (fr) | 2005-03-22 | 2006-09-28 | Basf Plant Science Gmbh | Procede de production d'acides gras c20 et c22 polyinsatures avec au moins quatre liaisons doubles dans des plantes transgeniques |
JP2008515406A (ja) * | 2004-10-06 | 2008-05-15 | ユーティーアイ リミテッド パートナーシップ | 植物におけるオレオシン発現のモジュレーションの方法 |
EP2166071A2 (fr) | 2003-08-01 | 2010-03-24 | BASF Plant Science GmbH | Procédé de production d'acides gras polyinsaturés chez des organismes transgéniques |
EP2177605A1 (fr) | 2006-10-06 | 2010-04-21 | BASF Plant Science GmbH | Procédé de production d'acides gras polyinstaurés dans des organimes transgéniques non-humains |
US7786355B2 (en) | 2000-11-17 | 2010-08-31 | Metabolix, Inc. | Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways |
WO2011023539A1 (fr) * | 2009-08-31 | 2011-03-03 | Basf Plant Science Company Gmbh | Molécules d'acide nucléique régulatrices pour l'amplification de l'expression génétique spécifique des graines et/ou préférentielle dans les graines dans des plantes |
EP2365063A1 (fr) | 2003-03-31 | 2011-09-14 | University Of Bristol | Nouvelles acyltransférases végétales spécifiques aux acides gras insaturés multiples à chaîne longue |
EP2366781A1 (fr) | 2005-11-24 | 2011-09-21 | BASF Plant Science GmbH | Procédé de production d'acides gras non saturés delta 5 dans des organismes transgéniques |
EP2380984A2 (fr) | 2006-02-16 | 2011-10-26 | BASF Plant Science GmbH | Acide nucléique |
EP2471930A1 (fr) | 2002-12-20 | 2012-07-04 | Metanomics GmbH & Co. KGaA | Procédé de production d'aminoacides |
DE112009003708T5 (de) | 2008-12-12 | 2012-09-13 | Basf Plant Science Gmbh | Desaturasen und Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren in transgenenOrganismen |
EP2623584A1 (fr) | 2004-02-27 | 2013-08-07 | BASF Plant Science GmbH | Procédé de fabrication de plusieurs acides gras insaturés dans des plantes transgéniques |
EP2826864A3 (fr) * | 2008-07-01 | 2015-05-06 | BASF Plant Science GmbH | Promoteurs dérivés de brassica napus pour l'expression génique spécifique de semences |
WO2015092709A1 (fr) | 2013-12-17 | 2015-06-25 | Basf Plant Science Company Gmbh | Procédés de conversion de la spécificité de substrat de désaturases |
US9428757B2 (en) | 2009-08-31 | 2016-08-30 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing seed-specific gene expression in plants promoting enhanced polyunsaturated fatty acid synthesis |
US9828607B2 (en) | 2009-08-31 | 2017-11-28 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993010240A1 (fr) * | 1991-11-15 | 1993-05-27 | E.I. Du Pont De Nemours And Company | GENES DE β-CETOACYL-ACP-SYNTHETASE II, OBTENUS A PARTIR DE PLANTES |
-
1993
- 1993-04-02 WO PCT/CA1993/000141 patent/WO1993020216A1/fr active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993010240A1 (fr) * | 1991-11-15 | 1993-05-27 | E.I. Du Pont De Nemours And Company | GENES DE β-CETOACYL-ACP-SYNTHETASE II, OBTENUS A PARTIR DE PLANTES |
Non-Patent Citations (11)
Title |
---|
BIOLOGICAL CHEMISTRY HOPPE-SEYLER vol. 372, August 1991, page 537 MURPHY, D.J., ET AL. 'Molecular and biochemical mechanisms of storage oil-body formation and mobilisation in oilseeds' * |
BIOTECHNOLOGY vol. 7, no. 9, September 1989, NEW YORK US pages 929 - 932 VANDEKERCKHOVE, J., ET AL. 'Enkephalins produced in transgenic plants using modified 2S seed storage proteins' * |
EMBL Nucleic Acid Sequence Database Accession No. X62353 20-2-1992 Release 31 A. thaliana gene for oleosin * |
J. EXP. BOT., SUPPL., MEETING HELD APRIL 7-12, 1991. vol. 42, no. 238, 1991, page 47 BATCHELDER, C., ET AL. 'Molecular genetics of oil body membrane proteins in Brassica napus and Arabidopsis' * |
PLANT MOLECULAR BIOLOGY. vol. 15, 1990, DORDRECHT, THE NETHERLANDS. pages 905 - 912 YAMAGUCHI-SHINOZAKI, K., ET AL. 'Analysis of an ABA-responsive rice gene promoter in transgenic tobacco' * |
PLANT MOLECULAR BIOLOGY. vol. 17, 1991, DORDRECHT, THE NETHERLANDS. pages 985 - 993 VILARDELL, J., ET AL. 'Regulation of the maize rab17 gene promoter in transgenic heterologous systems' * |
PLANT MOLECULAR BIOLOGY. vol. 18, no. 6, April 1992, DORDRECHT, THE NETHERLANDS. pages 1177 - 1179 VAN ROOIJEN, G.J.H. 'Nucleotide sequence of an Arabidopsis thaliana oleosin gene' * |
PLANT PHYSIOLOGY. vol. 96, 1991, ROCKVILLE, MD, USA. pages 1395 - 1397 LEE, K., ET AL. 'Genomic nucleotide sequence of a Brassica napus 20-kilodalton oleosin gene' * |
PLANT PHYSIOLOGY. vol. 97, 1991, ROCKVILLE, MD, USA. pages 1051 - 1058 HOLBROOK, LA., ET AL. 'Oilbody proteins in microspore-derived embryos of Brassica napus' * |
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA vol. 88, July 1991, WASHINGTON US pages 6181 - 6185 LEE, W.S., ET AL 'Maize oleosin is correctly targeted to seed oil bodies in Brassic napus transformed with the maize oleosin gene' * |
THE PLANT CELL. vol. 1, no. 10, 1989, ROCKVILLE, MD, USA. pages 969 - 976 MARCOTTE, W.R., ET AL. 'Abscisic acid-responsive sequences from the Em gene of wheat' * |
Cited By (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7091401B2 (en) | 1991-02-22 | 2006-08-15 | Sembiosys Genetics Inc. | Expression of epidermal growth factor in plant seeds |
WO1996021029A1 (fr) * | 1994-12-30 | 1996-07-11 | University Technologies International, Inc. | Proteines de corps huileux utilisees comme supports de proteines de valeur elevee |
US6441278B1 (en) | 1996-07-03 | 2002-08-27 | Cargill Incorporated | Canola oil having increased oleic acid and decreased linolenic acid content |
US5850026A (en) * | 1996-07-03 | 1998-12-15 | Cargill, Incorporated | Canola oil having increased oleic acid and decreased linolenic acid content |
US6063947A (en) * | 1996-07-03 | 2000-05-16 | Cargill, Incorporated | Canola oil having increased oleic acid and decreased linolenic acid content |
US7741542B2 (en) | 1996-07-03 | 2010-06-22 | Cargill, Incorporated | Canola oil having increased oleic acid and decreased linolenic acid content |
US6583303B1 (en) | 1996-07-03 | 2003-06-24 | Cargill, Incorporated | Canola oil having increased oleic acid and decreased linolenic acid content |
US5981841A (en) * | 1996-08-30 | 1999-11-09 | Monsanto Company | Early seed 5' regulatory sequence |
WO1998045461A1 (fr) * | 1997-04-09 | 1998-10-15 | Rhone-Poulenc Agro | Region regulatrice 5' d'oleosine servant a la modification de la composition lipidique de graines vegetales |
US5977436A (en) * | 1997-04-09 | 1999-11-02 | Rhone Poulenc Agrochimie | Oleosin 5' regulatory region for the modification of plant seed lipid composition |
EP1967589A3 (fr) * | 1997-04-09 | 2008-12-24 | Bayer CropScience S.A. | Région régulatrice d'oléosine 5 pour la modification d'une composition lipide de graine de plante |
AU739442B2 (en) * | 1997-04-09 | 2001-10-11 | Rhone-Poulenc Agro | An oleosin 5' regulatory region for the modification of plant seed lipid composition |
EP1002067A1 (fr) * | 1997-07-18 | 2000-05-24 | Carnegie Institution Of Washington | Region de regulation precoce puissante de gene specifique aux semences |
EP1002067A4 (fr) * | 1997-07-18 | 2004-10-27 | Carnegie Inst Of Washington | Region de regulation precoce puissante de gene specifique aux semences |
US6586658B1 (en) | 1998-03-06 | 2003-07-01 | Metabolix, Inc. | Modification of fatty acid metabolism in plants |
WO2000031283A3 (fr) * | 1998-11-20 | 2000-11-23 | Dow Agrosciences Llc | Sequences regulatrices utiles pour l'expression genetique dans des tissus embryonnaires vegetaux |
WO2000031283A2 (fr) * | 1998-11-20 | 2000-06-02 | Dow Agrosciences Llc | Sequences regulatrices utiles pour l'expression genetique dans des tissus embryonnaires vegetaux |
US7026526B2 (en) | 2000-02-11 | 2006-04-11 | Metabolix, Inc. | Multi-gene expression constructs containing modified inteins |
US7741530B2 (en) | 2000-02-11 | 2010-06-22 | Metabolix, Inc. | Multi-gene expression constructs containing modified inteins |
US8293971B2 (en) | 2000-02-11 | 2012-10-23 | Metabolix, Inc. | Multi-gene expression constructs containing modified inteins |
WO2001090386A2 (fr) * | 2000-05-24 | 2001-11-29 | The University Of British Columbia | Region regulatrice de genes promouvant une transcription precoce specifique de graines |
WO2001090386A3 (fr) * | 2000-05-24 | 2002-06-20 | Univ British Columbia | Region regulatrice de genes promouvant une transcription precoce specifique de graines |
US7786355B2 (en) | 2000-11-17 | 2010-08-31 | Metabolix, Inc. | Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways |
EP2471930A1 (fr) | 2002-12-20 | 2012-07-04 | Metanomics GmbH & Co. KGaA | Procédé de production d'aminoacides |
WO2004076617A2 (fr) | 2003-02-27 | 2004-09-10 | Basf Plant Science Gmbh | Procede de production d'acides gras polyinsatures |
EP2390313A1 (fr) | 2003-03-31 | 2011-11-30 | University Of Bristol | Nouvelles acyltransférases végétales spécifiques aux acides gras insaturés multiples à chaîne longue |
EP2365063A1 (fr) | 2003-03-31 | 2011-09-14 | University Of Bristol | Nouvelles acyltransférases végétales spécifiques aux acides gras insaturés multiples à chaîne longue |
EP2172536A2 (fr) | 2003-08-01 | 2010-04-07 | BASF Plant Science GmbH | Procédé de production d'acides gras polyinsaturés chez des organismes transgéniques |
EP2166089A2 (fr) | 2003-08-01 | 2010-03-24 | BASF Plant Science GmbH | Procédé de fabrication d'acides gras insaturés de manière multiple dans des organismes transgéniques |
EP2169052A2 (fr) | 2003-08-01 | 2010-03-31 | BASF Plant Science GmbH | Procédé de fabrication d'acides gras insaturés de manière multiple dans des organismes transgéniques |
EP2166090A2 (fr) | 2003-08-01 | 2010-03-24 | BASF Plant Science GmbH | Procédé de fabrication d'acides gras insaturés de manière multiple dans des organismes transgéniques |
EP2166069A2 (fr) | 2003-08-01 | 2010-03-24 | BASF Plant Science GmbH | Procédé de production d'acides gras polyinsaturés chez des organismes transgéniques |
EP3395945A1 (fr) | 2003-08-01 | 2018-10-31 | BASF Plant Science GmbH | Procédé de production de plusieurs acides gras insaturés dans des organismes transgeniques |
EP2166070A2 (fr) | 2003-08-01 | 2010-03-24 | BASF Plant Science GmbH | Procédé de production d'acides gras polyinsaturés chez des organismes transgéniques |
EP2169053A2 (fr) | 2003-08-01 | 2010-03-31 | BASF Plant Science GmbH | Procédé de fabrication d'acides gras insaturés de manière multiple dans des organismes transgéniques |
EP2166071A2 (fr) | 2003-08-01 | 2010-03-24 | BASF Plant Science GmbH | Procédé de production d'acides gras polyinsaturés chez des organismes transgéniques |
EP2623584A1 (fr) | 2004-02-27 | 2013-08-07 | BASF Plant Science GmbH | Procédé de fabrication de plusieurs acides gras insaturés dans des plantes transgéniques |
WO2005083053A2 (fr) | 2004-02-27 | 2005-09-09 | Basf Plant Science Gmbh | Procede pour produire des acides gras $g(v)-3 insatures dans des organismes transgeniques |
JP2008515406A (ja) * | 2004-10-06 | 2008-05-15 | ユーティーアイ リミテッド パートナーシップ | 植物におけるオレオシン発現のモジュレーションの方法 |
WO2006100241A2 (fr) | 2005-03-22 | 2006-09-28 | Basf Plant Science Gmbh | Procede de production d'acides gras c20 et c22 polyinsatures avec au moins quatre liaisons doubles dans des plantes transgeniques |
EP2366781A1 (fr) | 2005-11-24 | 2011-09-21 | BASF Plant Science GmbH | Procédé de production d'acides gras non saturés delta 5 dans des organismes transgéniques |
EP2388332A1 (fr) | 2005-11-24 | 2011-11-23 | BASF Plant Science GmbH | Procédé de production d'acides gras delta 5-insaturés dans des organismes transgénétiques |
EP2380984A2 (fr) | 2006-02-16 | 2011-10-26 | BASF Plant Science GmbH | Acide nucléique |
EP2177605A1 (fr) | 2006-10-06 | 2010-04-21 | BASF Plant Science GmbH | Procédé de production d'acides gras polyinstaurés dans des organimes transgéniques non-humains |
EP2182056A1 (fr) | 2006-10-06 | 2010-05-05 | BASF Plant Science GmbH | Procédé de production d'acides gras polyinsaturés dans des organismes transgéniques non-humains |
EP2826864A3 (fr) * | 2008-07-01 | 2015-05-06 | BASF Plant Science GmbH | Promoteurs dérivés de brassica napus pour l'expression génique spécifique de semences |
DE112009003708T5 (de) | 2008-12-12 | 2012-09-13 | Basf Plant Science Gmbh | Desaturasen und Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren in transgenenOrganismen |
EP2669380A1 (fr) | 2008-12-12 | 2013-12-04 | BASF Plant Science GmbH | Désaturases et procédé de production d'acides gras poly-non-saturés dans les organismes transgéniques |
US9970019B2 (en) | 2009-08-31 | 2018-05-15 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing seed-specific and/or seed-preferential gene expression in plants |
EP3153584A3 (fr) * | 2009-08-31 | 2017-07-12 | BASF Plant Science Company GmbH | Molécules d'acide nucléique régulatrices pour l'amélioration de l'expression génique spécifique et/ou préférentielle de semences dans des plantes |
RU2559534C2 (ru) * | 2009-08-31 | 2015-08-10 | Басф Плант Сайенс Компани Гмбх | Регуляторные молекулы нуклеиновых кислот для усиления семя-специфичной и/или семя-предпочтительной генной экспрессии в растениях |
US9150871B2 (en) | 2009-08-31 | 2015-10-06 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing seed-specific and/or seed-preferential gene expression in plants |
US9428757B2 (en) | 2009-08-31 | 2016-08-30 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing seed-specific gene expression in plants promoting enhanced polyunsaturated fatty acid synthesis |
CN102575259B (zh) * | 2009-08-31 | 2017-04-12 | 巴斯夫植物科学有限公司 | 用于增强植物中种子特异的和/或种子优先的基因表达的调节性核酸分子 |
EP3156492A1 (fr) * | 2009-08-31 | 2017-04-19 | BASF Plant Science Company GmbH | Molécules d'acide nucléique régulatrices pour renforcer l'expression génique spécifique et/ou préférentielle de semences dans des plantes |
EP3156491A1 (fr) * | 2009-08-31 | 2017-04-19 | BASF Plant Science Company GmbH | Molécules d'acide nucléique régulatrices pour l'amélioration de l'expression génique spécifique et/ou préférentielle à la semence dans des plantes |
EP3156490A3 (fr) * | 2009-08-31 | 2017-07-05 | BASF Plant Science Company GmbH | Molécules d'acide nucléique régulatrices pour l'amélioration de l'expression génique spécifique et/ou préférentielle à la semence dans des plantes |
US11708578B2 (en) | 2009-08-31 | 2023-07-25 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
US9828607B2 (en) | 2009-08-31 | 2017-11-28 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
WO2011023539A1 (fr) * | 2009-08-31 | 2011-03-03 | Basf Plant Science Company Gmbh | Molécules d'acide nucléique régulatrices pour l'amplification de l'expression génétique spécifique des graines et/ou préférentielle dans les graines dans des plantes |
US10041081B2 (en) | 2009-08-31 | 2018-08-07 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing seed-specific and/or seed-preferential gene expression in plants |
US10041082B2 (en) | 2009-08-31 | 2018-08-07 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing seed-specific and/or seed-preferential gene expression in plants |
US10041083B2 (en) | 2009-08-31 | 2018-08-07 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing seed-specific and/or seed-preferential gene expression in plants |
CN102575259A (zh) * | 2009-08-31 | 2012-07-11 | 巴斯夫植物科学有限公司 | 用于增强植物中种子特异的和/或种子优先的基因表达的调节性核酸分子 |
RU2692924C2 (ru) * | 2009-08-31 | 2019-06-28 | Басф Плант Сайенс Компани Гмбх | Регуляторные молекулы нуклеиновых кислот для усиления семя-специфичной и/или семя-предпочтительной генной экспрессии в растениях |
US10689657B2 (en) | 2009-08-31 | 2020-06-23 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants |
WO2015092709A1 (fr) | 2013-12-17 | 2015-06-25 | Basf Plant Science Company Gmbh | Procédés de conversion de la spécificité de substrat de désaturases |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0633940B1 (fr) | Elements cis de proteines des corps oleiferes, servant de signaux de regulation | |
WO1993020216A1 (fr) | Elements cis de proteines des corps oleiferes, servant de signaux de regulation | |
Elmayan et al. | Evaluation in tobacco of the organ specificity and strength of the rolD promoter, domain A of the 35S promoter and the 35S2 promoter | |
US6777591B1 (en) | Legume-like storage protein promoter isolated from flax and methods of expressing proteins in plant seeds using the promoter | |
CA2006454C (fr) | Regulation transcriptionnelle specifique des tubercules de pommes de terre | |
ZA200103557B (en) | Novel expression cassette for expressing genes in plant seed. | |
EP1212438B1 (fr) | Promoteurs specifiques des graines de lin | |
Saalbach et al. | The vacuolar targeting signal of the 2S albumin from Brazil nut resides at the C terminus and involves the C-terminal propeptide as an essential element | |
US7642346B2 (en) | Flax seed specific promoters | |
US7211712B2 (en) | Seed-preferred regulatory elements | |
WO1993021320A1 (fr) | Proteines de corps huileux utilisees en tant que vecteurs de peptides de grande valeur dans des plantes | |
CA2133417C (fr) | Elements cis de proteine de substance huileuse, utilises comme signaux regulateurs | |
US20070006343A1 (en) | Modified oleosins | |
Firek et al. | Endoplasmic reticulum targeting of active modified β-glucuronidase (GUS) in transgenic tobacco plants | |
US6784342B1 (en) | Regulation of embryonic transcription in plants | |
CA2310304C (fr) | Promoteurs specifiques de graines de lin | |
Kim et al. | Analysis of the Glycinin Gy2 Promoter Activity in Soybean Protoplasts and Transgenic Tobacco Plants | |
AU678136C (en) | Oil-body proteins as carriers of high-value peptides in plants | |
EP1644507A1 (fr) | Nouveaux promoteurs de la rubisco et leurs utilisations | |
Garrett | Functional mapping of pea legumin upstream regulatory elements using TI plasmid vectors | |
CA2383376A1 (fr) | Promoteurs specifiques des graines de lin | |
ZA200202399B (en) | Flax seed specific promoters. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
WR | Later publication of a revised version of an international search report | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
EX32 | Extension under rule 32 effected after completion of technical preparation for international publication | ||
LE32 | Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 944550 Country of ref document: FI Ref document number: 2133417 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1993907716 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1993907716 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08313098 Country of ref document: US |
|
WWG | Wipo information: grant in national office |
Ref document number: 1993907716 Country of ref document: EP |